Research
Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2573 (Published 02 May 2013) Cite this as: BMJ 2013;346:f2573
Related articles
- Research Published: 18 March 2009; BMJ 338 doi:10.1136/bmj.b880
- Research Published: 31 January 2011; BMJ 342 doi:10.1136/bmj.d124
- Research Article Published: 30 March 1991; British Medical Journal 302 doi:10.1136/bmj.302.6779.766
- Research Published: 13 May 2010; BMJ 340 doi:10.1136/bmj.c2442
- RESEARCH Published: 05 July 2007; BMJ doi:10.1136/bmj.39261.471806.55
- Research Published: 19 July 2007; BMJ 335 doi:10.1136/bmj.39261.471806.55
- Research Published: 22 June 2011; BMJ 342 doi:10.1136/bmj.d3651
- Research Published: 07 July 2009; BMJ 339 doi:10.1136/bmj.b2584
- ResearchPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2Published: 26 June 2008; BMJ 336 doi:10.1136/bmj.39609.449676.25
- Research Published: 16 August 2011; BMJ 343 doi:10.1136/bmj.d4656
- Research Published: 20 November 2009; BMJ 339 doi:10.1136/bmj.b4229
- Research Published: 21 June 2012; BMJ 344 doi:10.1136/bmj.e4181
- Research Published: 28 July 2014; BMJ 349 doi:10.1136/bmj.g4606
- Research Published: 11 November 2015; BMJ 351 doi:10.1136/bmj.h5441
- Research Published: 06 September 2016; BMJ 354 doi:10.1136/bmj.i4482
- Research Published: 24 January 2018; BMJ 360 doi:10.1136/bmj.j5855
See more
- Prescribing parkrun: medicalising a walk in the parkBMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670
- GPs can prescribe tirzepatide to priority patient groups from JuneBMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665
- Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reportsBMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287
- Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog findsBMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
Cited by...
- Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank
- Modifiable Risk Factors for Stroke, Dementia, and Late-Life Depression: A Systematic Review and DALY Weighted Risk Factors for a Composite Outcome
- Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink
- Age-Related Differences in the Role of Risk Factors for Ischemic Stroke
- Development of rapid and effective risk prediction models for stroke in the Chinese population: a cross-sectional study
- Development and internal validation of a multivariable prediction model for 6-year risk of stroke: a cohort study in middle-aged and elderly Chinese population
- Anticoagulation in atrial fibrillation
- GPs familiarity with and use of cardiovascular clinical prediction rules: a UK survey study
- What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation
- Real-world effect of antidepressants for depressive disorder in primary care: protocol of a population-based cohort study
- Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink
- Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports
- Self-Reported Stroke Risk Stratification: Reasons for Geographic and Racial Differences in Stroke Study
- Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
- PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
- Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study
- How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
- Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study
- New Strategy to Reduce the Global Burden of Stroke
- Is Blood Pressure Control for Stroke Prevention the Correct Goal?: The Lost Opportunity of Preventing Hypertension
- Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study
- Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
- Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
- Assessing the Performance of the Framingham Stroke Risk Score in the Reasons for Geographic and Racial Differences in Stroke Cohort
- Separate prediction of intracerebral hemorrhage and ischemic stroke
- A Prospective Cohort Study of Patients With Transient Ischemic Attack to Identify High-Risk Clinical Characteristics
- Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score